Quinsam Reports Strong Q2/2018 Results TORONTO, Aug. 22,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
40
Quinsam Reports Strong Q2/2018 Results

TORONTO, Aug. 22, 2018 (GLOBE NEWSWIRE) -- Quinsam Capital Corporation (CSE:QCA) (“Quinsam” or the “Company”) is pleased to announce strong Q2/2018 results, with net income of $3.3 million ($0.03 per share) as compared to a loss of $0.3 million ($0.01 per share) in Q2/2017. Net income for Q2/2018 included a non-cash charge of $0.4 million for stock-based compensation and $0.5 million for non-cash deferred tax provision.

“We entered the quarter with shareholders’ equity of $36.8 million, so our return on equity in the quarter after non-cash charges was nearly 10%. Our return in the quarter before non-cash charges was over 11%.” said Roger Dent, CEO of Quinsam. “At quarter-end, we had net assets of approximately $0.34 per share outstanding ($0.35 before deferred taxes).”

Recent Activities

The Company has deployed the capital raised in the financings announced earlier in 2018 and in 2017. Quinsam is now actively managing its portfolio in the pursuit of optimal risk/reward performance.  We take a variety of operational approaches to our investments with the same investment goal:  to achieve strong investment overall performance while mitigating the downside risk whenever possible. Some are long-term strategic plays, some are more controlled risk investments through convertible debentures and some are more opportunistic market plays.

As a result, Quinsam has made some opportunistic dispositions in 2018.  Dosecann was acquired by Auxly Cannabis Group Inc. (“Auxly”) and Quinsam received Auxly shares and warrants.  Auxly was not really an investment where we felt we could add a great deal of value, so the Company disposed of its Auxly shares at prices ranging from $1.06 to $1.28 (cost $0.80; recently trading at $0.87).  We retain our warrant holding.  We have sold our Khiron Life Sciences Corp. shares at prices ranging from $1.02 to $1.30 but retain our warrant position (cost $1.00; recently trading at $0.98).  We have disposed of our Cannex Capital Holdings Inc. shares at a price of $1.34 but retain our warrant position (cost $1.00; recently trading at $0.88).  We converted our Hiku Brands Company Ltd. debentures after the announcement of its acquisition by Canopy Growth Corporation. We sold our resulting shares at a price of $1.72 prior to the Canopy/Constellation Brands news and retained our warrant position (cost $1.24; recently trading at $2.22). We sold our position in 48North Cannabis Corp. at a price of $0.99 (cost $0.50; recently trading at $0.68) but retain our warrant position.     

Quinsam now holds in excess of 15 million warrants issued by a wide variety of cannabis companies. This represents well over 0.1 warrant of other issuers attributable to each outstanding Quinsam share.  Unless a warrant is listed, our policy is to value warrants at the lower of nil or intrinsic value.  Accordingly, many of these warrants are carried on our books at nil value.  Management believes that our warrant portfolio adds material upside leverage to the Company if the underlying shares perform well.

A number of our issuers continue to pursue liquidity events.  Most recently, Aura Health Inc. (“Aura”) began trading on the Canadian Securities Exchange (the “CSE”) last week.  Quinsam held a group of Aura securities including convertible debentures, shares and warrants.  All are well in the money at the recent trading price.

Several of our issuers are progressing to listings in the near term including Crossgate Capital Corporation (doing business as Next Green Wave), ALQ Gold Corporation,  RMMI Corp., Irri-Al Tal Ltd. and Biome Grow Inc.

Three of our issuers have announced major, transformative transactions.

Xanthic Biopharma Inc. shares were halted some weeks ago at $0.25 (our current carrying value).  It is merging with Green Growth Brands Ltd. and a syndicate is in the process of raising $55 million at a planned effective issue price of approximately $0.36.

Two of our issuers have announced a combination with one another.  Lineage Grow Company Ltd. (“Lineage”) has announced that it is merging with FLRish Inc. (doing business as Harborside). “Harborside is in our opinion one of the premier companies in the California cannabis business,” said Roger Dent. “We think that the resulting issuer will become one of the most notable public US cannabis issuers.”  Because the merged company will now become focused on the California cannabis market, Quinsam and Lineage have agreed to terminate their previously announced agreement whereby Lineage would acquire Quinsam’s right to a 35% equity stake in a Maryland dispensary. Quinsam expects to receive 200,000 Lineage shares as a result of the termination agreement. 

We have made a number of new investments since our last update, including the following:

We are investing $500,000 in units of Apogee Opportunities (USA) Inc. (to be operating as Halo Labs).  Halo Labs is an Oregon-based producer that expects to list on the CSE in 2018.

We are acquiring US$400,000 in convertible debentures of Green Tree International, Inc. (doing business as Amercanex). Amercanex was created by a group of former senior US commodities executives and is developing a highly sophisticated exchange and data company relating to cannabis. 

We are acquiring $495,000 of CannAmerica Brands Corp. (“CannAmerica”), which expects to list on the CSE in 2018. CannAmerica has a very interesting brand licensing approach that creates a very favourable cash flow business model. We think that the company will be well received by the market.    We are acquiring $390,000 in common shares of Ballistic Capital Corp. (“Ballistic”). This will make us a near 10% shareholder of this company. Ballistic is involved with the disposal of cannabis waste in California. Cannabis waste disposal is a new and, we think, a very interesting business that has been created by the legalization of cannabis in the state.  

We have acquired $300,000 of convertible debentures and warrants in Theracann International Benchmark Corporation (“Theracann”), which also expects a liquidity event in 2018.  Theracann is a Canadian cannabis company with a number of interesting aspects including an ACMPR application, grow technology and a very interesting bio-molecular technology that allows for cannabis tracking by regulators etc. 

“While the cannabis sector has shown and likely will show significant volatility, we still see many extremely interesting investment opportunities,” said Roger Dent.  “We will continue to look for opportunities that are generally unavailable to the typical investor.  We will also remain focused on maintaining a tight cost structure.  By bringing a disciplined approach to this rather volatile sector, we have to date been able to deliver strong results for our investors.”  

The Quinsam board has voted to implement a management performance bonus plan.  The management group, in aggregate, will be eligible to earn bonuses of 5% of pre-tax gains generated on investments.  Payments will be made on an annual basis.  Quinsam is of the view that this bonus plan aligns interests of shareholders and management and compares favourably with plans of similar entities which, typically have much larger bonus pools.

Issuer Bid

The Company recently announced an issuer bid to acquire up to 5,928,951 common shares. To date, no shares have been purchased.

About Quinsam Capital Corporation

Quinsam is a merchant bank based in Canada that is focusing on cannabis-related investments.  Our merchant banking business may encompass a range of activities including acquisitions, advisory services, lending activities and portfolio investments. Quinsam invests its capital for its own account in assets, companies or projects which we believe are undervalued and where we see a viable plan for unlocking such value. We do not invest on behalf of any third party and we do not offer investment advice. 

Generally, Quinsam does not believe that individual investments are material reportable events.  Quinsam chooses to announce certain investments once the company is certain that it has finished buying its position because the Company feels that this information helps Quinsam’s investors understand its investment decision making process. Generally, Quinsam does not announce the sale of investments.  

For further information please contact:

Roger Dent, CEO (647) 993-5475 roger@quinsamcapital.com

This press release may contain forward-looking statements relating to anticipated future events, results, circumstances, performance or expectations that are not historical facts but instead represent our beliefs regarding future events, which are inherently uncertain. Forward-looking statements can often, but not always, be identified by forward-looking words such as “anticipate”, “believe”, “continue”, “expect”, “goal”, “plan”, “intend”, “estimate”, “may”, “project”, “predict”, “potential”, “target”, and “will” or similar words suggesting future outcomes, or other expectations, beliefs, plans, objectives, assumptions, intentions or statements about future events or performance.

By their nature, forward-looking statements require us to make assumptions which include, among other things, that (i) Quinsam will have sufficient capital under management to effect its business strategies, (ii) the business strategies will produce the results intended by Quinsam, and (iii) the markets will react and perform in a manner consistent with the business strategies.

Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking information. The Company believes that the expectations reflected in the forward-looking information are reasonable but no assurance can be given that these expectations will prove to be correct. Some of the risks and other factors that could cause actual results to differ materially from those expressed in forward-looking information expressed in this press release include, but are not limited to: cannabis companies Quinsam has invested in obtaining and maintaining regulatory approvals including acquiring and renewing U.S. state, local or other licenses, and the uncertainty of existing protection from U.S. federal or other prosecution; regulatory or political change such as changes in applicable laws and regulations, including U.S. state-law legalization; market and general economic conditions of the cannabis sector or otherwise, interest rates, regulatory and statutory developments, the nature of the Company’s investments, the available opportunities and competition for investments, the concentration of the Company’s  investments in certain industries and sectors, reliance on key personnel, risks affecting the Company’s investments, management of the growth of the Company, and exchange rate fluctuations. Readers are cautioned that the foregoing list of risks and factors is not exhaustive. Although the Company has attempted to identify important factors that could cause actual events or results to differ materially from those described in forward-looking information, there may be other factors that cause events or results to differ from those intended, anticipated or estimated.

The forward-looking information contained herein is provided as at the date of this press release, based upon the opinions and estimates of management and information available to management as at the date of this press release. The Company does not undertake and specifically disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, unless required by applicable law. Readers are cautioned not to place undue reliance on forward-looking information contained in this press release.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Robert Half's Parent Support Earns Fortune Recognition

Updated Category News Views 92

A workplace award rarely moves a staffing stock by itself, and it shouldn’t. Still, Fortune naming Robert Half among its Best Workplaces for Parents for 2026 is more than decorative corporate wallpaper. In the talent business, the company’s own ability to recruit, retain and support people is part of the product. Clients hire Robert Half because they need skilled...

Continue Reading
NextPlat’s 150-Patient Test Has a Long Road Ahead

Updated Category News Views 114

A strip of pills can look mundane, yet it is where this entire NextPlat pitch either earns its keep or falls apart. PharmcoRx has signed a partner pharmacy agreement with MedSure Systems for a 150-patient Medicare medication-adherence pilot in South Florida. That is a small starting line, no two ways around it. Still, the mechanics are more interesting than another vague...

Continue Reading
Holland America Puts 2028 Alaska Demand on Display

Updated Category News Views 156

Alaska’s interior is where a cruise brochure either earns its keep or gets exposed. Holland America Line is opening bookings for 2028 Alaska Cruisetours nearly two years ahead, tying a coast-and-land product to the reimagined Oosterdam’s Alaska debut. That is not merely another itinerary release. It is a fairly deliberate attempt to sell a bigger, longer and...

Continue Reading
Wenge AI Removes a Small Friction Point for ScienceOra

Updated Category News Views 31

Scientific software rarely loses users because the underlying model is too clever; it loses them because getting through the front door is a nuisance. Wenge AI has addressed that unglamorous problem by adding Google and Apple sign-in options to the international version of ScienceOra, its AI-powered research and decision-support platform. This is not the sort of...

Continue Reading
JDEnergy's RE+ Push Meets a Grid Hungry for Storage

Updated Category News Views 90

Certification Is Useful, Not a Victory Lap A battery box earning a safety certificate is not usually thrilling stuff, but the timing matters here. On Nov. 19, 2026, JDEnergy laid out its North American storage pitch at RE+ in Las Vegas while electricity demand is getting shoved higher by industrial buildout and AI data centers. Add more variable renewable generation to an...

Continue Reading
Vision Marine's Cash Cleanup Meets a Hard Reality Ahead

Updated Category News Views 162

A boat dealer slashing debt by $27.5 million deserves a nod, even when the rest of the ledger still makes your eyebrows climb. Vision Marine Technologies turned fiscal 2026 into a working-capital cleanup job: inventory came down hard, floor-plan financing nearly vanished, and operating cash flow finally turned positive. For NASDAQ:VMAR, that is real progress. It is not,...

Continue Reading
SAP Execution Can Steady Operations Beyond Spreadsheets

Updated Category News Views 87

Spreadsheets breed little kingdoms, and SAP is often left outside the gate. That is the operational mess Martin Rowan, managing partner at Reveal USA, Inc. in Naperville, is taking aim at in a Nov. 19, 2026 HelloNation feature. His central point is not terribly glamorous, but it is dead right: a company gets less stable when it uses SAP to explain yesterday's results...

Continue Reading
LKQ’s Europe ERP Mess Turns Into a Credibility Test

Updated Category News Views 98

A software rollout should not be able to punch a company in the teeth twice, yet LKQ shareholders have watched precisely that ugly movie in 2026. The October 23 disclosure was a real gut-check: an immediate CEO departure, a $16 million net loss, and renewed acknowledgement that the German enterprise-resource-planning rollout was disrupting Europe. Shares fell $5.05, or...

Continue Reading
Huawei's Financial AI Push Targets Scale, Not Demos

Updated Category News Views 23

Banking AI has reached the point where a clever chatbot barely moves the needle. Huawei's message at Singapore FinTech Festival 2026 was aimed squarely at that harder, more expensive problem: turning AI from a scattered pilot project into machinery a financial institution can operate, govern, repeat, and improve without handing over its crown jewels. Ownership Is the...

Continue Reading
CMS Audit Proposal Reopens Medicare Advantage Risk

Updated Category News Views 44

A regulator just tossed a rusted anchor into managed care's earnings model. CMS's proposed Comprehensive Regulations to Uncover Suspicious Healthcare rule, dubbed CRUSH and numbered CMS-6098-P, puts Medicare Advantage risk-adjustment audits back at center stage. The headline nobody can casually wave away: audit findings from sampled enrollees could be extrapolated across...

Continue Reading

Top 5 Most Recently Viewed Articles

Anticipating Autohome Inc.'s Financial Results for 2025

Updated Category News Views 150

Autohome Inc.'s Upcoming Financial Results Announcement Autohome Inc. (NYSE: ATHM) is on the verge of announcing its financial results for the second quarter and six months period ending June 30, 2025. As a leading platform for automobile consumers, Autohome continues to grow and adapt in an evolving market. Key Details on the Earnings Announcement The earnings report...

Continue Reading
NEXGEL Welcomes Industry Expert Kip Crecca to Advisory Team

Updated Category News Views 100

NEXGEL Expands Scientific Expertise with New Appointment NEXGEL, Inc. (NASDAQ: NXGL), renowned for its innovative medical and over-the-counter (OTC) products, has recently announced an exciting development. The company is thrilled to welcome Kip Crecca to its Scientific Advisory Board. This strategic addition showcases NEXGEL's dedication to enhancing its healthcare...

Continue Reading
Exciting Mixed-Use Development Takes Shape in Downtown Area

Updated Category News Views 318

Reimagining Urban Spaces: The Lewter District Development In an exciting development for urban living, RNGD and Emergent Properties are pioneering a remarkable mixed-use community known as the Lewter District. This project is set on a 1.5-acre plot, featuring 14 townhomes, a Class A office building, and an inviting farm-to-table restaurant, bar, and bakery. It's an...

Continue Reading
37th Parallel Expands DFW Footprint with Key Acquisition

Updated Category News Views 97

Picking Up Momentum in Dallas-Fort Worth Real Estate 37th Parallel Properties isn't messing around in the Dallas-Fort Worth market. They've snapped up Woodbridge Villas, a prime multifamily asset with 222 units tucked away in Sachse, Texas—a place with more charm than lawn gnomes in spring. This acquisition helps them expand their already hefty footprint in the South...

Continue Reading
Microchip Technology Announces Revenue Changes and Restructuring

Updated Category News Views 169

Microchip Technology's Updated Revenue Guidance for December Quarter Recently, Microchip Technology Incorporated, a prominent provider of smart embedded control solutions, has updated its revenue outlook for the upcoming quarter. The latest forecasts indicate a decline, with expectations set close to the lower end of their original guidance at $1.025 billion. This...

Continue Reading